HighTower Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.68M | Sell |
19,571
-1,103
| -5% | -$96.7K | ﹤0.01% | 1878 |
|
|
2026
Q1 | $1.87M | Buy |
20,674
+2,824
| +16% | +$259K | ﹤0.01% | 1757 |
|
|
2025
Q4 | $1.61M | Sell |
17,850
-17,108
| -49% | -$1.62M | ﹤0.01% | 1803 |
|
|
2025
Q3 | $3.44M | Sell |
34,958
-15,738
| -31% | -$1.56M | ﹤0.01% | 1327 |
|
|
2025
Q2 | $4.62M | Sell |
50,696
-43
| -0.1% | -$4.16K | 0.01% | 1120 |
|
|
2025
Q1 | $5.74M | Sell |
50,739
-2,915
| -5% | -$312K | 0.01% | 987 |
|
|
2024
Q4 | $5.67M | Sell |
53,654
-8,849
| -14% | -$949K | 0.01% | 997 |
|
|
2024
Q3 | $6.71M | Sell |
62,503
-262
| -0.4% | -$28.6K | 0.01% | 917 |
|
|
2024
Q2 | $6.77M | Sell |
62,765
-94,762
| -60% | -$11.2M | 0.01% | 876 |
|
|
2024
Q1 | $20.8M | Buy |
157,527
+42,170
| +37% | +$5.27M | 0.03% | 463 |
|
|
2023
Q4 | $14M | Buy |
115,357
+22,352
| +24% | +$2.49M | 0.02% | 577 |
|
|
2023
Q3 | $10.4M | Buy |
93,005
+9,491
| +11% | +$1.21M | 0.02% | 650 |
|
|
2023
Q2 | $12.2M | Buy |
83,514
+45,947
| +122% | +$6.24M | 0.02% | 580 |
|
|
2023
Q1 | $4.86M | Sell |
37,567
-1,066
| -3% | -$134K | 0.01% | 875 |
|
|
2022
Q4 | $4.93M | Sell |
38,633
-98
| -0.3% | -$11.4K | 0.01% | 863 |
|
|
2022
Q3 | $4.04M | Sell |
38,731
-1,925
| -5% | -$211K | 0.01% | 887 |
|
|
2022
Q2 | $4.29M | Buy |
40,656
+232
| +0.6% | +$27.5K | 0.01% | 891 |
|
|
2022
Q1 | $5.17M | Sell |
40,424
-31,341
| -44% | -$3.78M | 0.01% | 874 |
|
|
2021
Q4 | $8.85M | Buy |
71,765
+9,431
| +15% | +$1.23M | 0.02% | 652 |
|
|
2021
Q3 | $8.84M | Buy |
62,334
+6,883
| +12% | +$1.01M | 0.02% | 584 |
|
|
2021
Q2 | $8.61M | Buy |
55,451
+3,569
| +7% | +$578K | 0.02% | 577 |
|
|
2021
Q1 | $8.04M | Buy |
+51,882
| New | +$8.04M | 0.03% | 559 |
|
|
2020
Q4 | – | Sell |
-33,614
| Closed | -$4.44M | – | 2970 |
|
|
2020
Q3 | $4.44M | Buy |
33,614
+3,405
| +11% | +$445K | 0.02% | 594 |
|
|
2020
Q2 | $3.51M | Buy |
30,209
+4,900
| +19% | +$565K | 0.02% | 630 |
|
|
2020
Q1 | $2.48M | Sell |
25,309
-44,180
| -64% | -$5.79M | 0.02% | 675 |
|
|
2019
Q4 | $9.99M | Buy |
69,489
+2,796
| +4% | +$386K | 0.06% | 334 |
|
|
2019
Q3 | $8.87M | Sell |
66,693
-768
| -1% | -$99.2K | 0.05% | 367 |
|
|
2019
Q2 | $7.73M | Buy |
67,461
+3,577
| +6% | +$419K | 0.05% | 411 |
|
|
2019
Q1 | $7.89M | Buy |
63,884
+36,237
| +131% | +$4.12M | 0.05% | 363 |
|
|
2018
Q4 | $2.78M | Buy |
27,647
+2,453
| +10% | +$276K | 0.02% | 638 |
|
|
2018
Q3 | $3.22M | Buy |
25,194
+777
| +3% | +$92.4K | 0.02% | 664 |
|
|
2018
Q2 | $2.64M | Buy |
24,417
+1,958
| +9% | +$213K | 0.02% | 740 |
|
|
2018
Q1 | $2.38M | Sell |
22,459
-225
| -1% | -$26.1K | 0.02% | 754 |
|
|
2017
Q4 | $2.65M | Buy |
22,684
+50
| +0.2% | +$5.65K | 0.02% | 733 |
|
|
2017
Q3 | $2.57M | Sell |
22,634
-900
| -4% | -$104K | 0.02% | 727 |
|
|
2017
Q2 | $2.93M | Buy |
23,534
+3,405
| +17% | +$404K | 0.03% | 658 |
|
|
2017
Q1 | $2.38M | Buy |
20,129
+110
| +0.5% | +$12.5K | 0.02% | 702 |
|
|
2016
Q4 | $2.01M | Buy |
20,019
+3,046
| +18% | +$326K | 0.02% | 701 |
|
|
2016
Q3 | $2.15M | Sell |
16,973
-283
| -2% | -$35K | 0.02% | 639 |
|
|
2016
Q2 | $2.02M | Sell |
17,256
-3,822
| -18% | -$433K | 0.03% | 625 |
|
|
2016
Q1 | $2.19M | Buy |
21,078
+2,572
| +14% | +$249K | 0.01% | 687 |
|
|
2015
Q4 | $1.84M | Buy |
18,506
+5,334
| +40% | +$522K | 0.02% | 669 |
|
|
2015
Q3 | $1.2M | Sell |
13,172
-28,404
| -68% | -$2.85M | 0.02% | 806 |
|
|
2015
Q2 | $4.4M | Buy |
41,576
+1,062
| +3% | +$118K | 0.07% | 304 |
|
|
2015
Q1 | $4.63M | Sell |
40,514
-395
| -1% | -$45.1K | 0.07% | 311 |
|
|
2014
Q4 | $4.5M | Buy |
40,909
+736
| +2% | +$77.6K | 0.07% | 307 |
|
|
2014
Q3 | $3.92M | Buy |
40,173
+873
| +2% | +$85.9K | 0.07% | 325 |
|
|
2014
Q2 | $3.96M | Buy |
39,300
+353
| +0.9% | +$34.4K | 0.07% | 310 |
|
|
2014
Q1 | $3.58M | Buy |
38,947
+4,244
| +12% | +$391K | 0.07% | 327 |
|
|
2013
Q4 | $3.14M | Buy |
34,703
+1,152
| +3% | +$99.7K | 0.06% | 325 |
|
|
2013
Q3 | $2.66M | Sell |
33,551
-5,553
| -14% | -$437K | 0.07% | 346 |
|
|
2013
Q2 | $2.85M | Buy |
+39,104
| New | +$2.92M | 0.08% | 287 |
|
Other funds holding ZBH
HighTower Advisors's ZBH Position: Q2 2026 in Review
HighTower Advisors reduced its Zimmer Biomet (ZBH) stake by 5.3% in Q2 2026, selling an estimated $96.7K and leaving 19,571 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1878.
HighTower Advisors first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $20.8M in Q1 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- HighTower Advisors held 19,571 shares of Zimmer Biomet worth $1.68M as of Q2 2026.
- HighTower Advisors sold 1,103 Zimmer Biomet shares in Q2 2026, an estimated $96.7K.
- Zimmer Biomet made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1878 holding.
- HighTower Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- HighTower Advisors's Zimmer Biomet position peaked at $20.8M in Q1 2024.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.